grepcent / static financial knowledge base

Peer reviews

AI-assembled from public SEC filings

Life insurers peer review

Descriptive comparison assembled from public SEC filings and verified companyfacts.

Descriptive comparison — not investment advice. This feature-specific review is assembled from a frozen evidence pack of public SEC filing quotes and verified SEC companyfacts numbers. It is descriptive only and makes no judgment about which company is better. It is not a rating, recommendation, endorsement, forecast, or investment advice. Figures are as of their cited filing dates. See Disclaimer.

Methodology

The cluster is selected mechanically from public SEC SIC 6311 companies already present in grepcent's processed universe, sorted by latest reported revenue. It is separate from the property-and-casualty insurer review because life, annuity, reinsurance, and protection models have different statement structures. The review publishes no proprietary index-membership labels.

Pack hash: e1348d2d60a83937908d61c4284d0f72ce5c193c1cd2688c6b79acc9771b6b4c. Generated: 2026-07-21.

Verified Quantitative Matrix

Numbers are templated from frozen SEC companyfacts-derived facts already verified by grepcent. Fiscal periods and filing dates are shown in each cell; code-computed comparisons below only use calendar-aligned periods.

MetricMETPRURGACRBGLNCVOYAGNWBHFJXNGL
Revenue77,084,000,000
FY 2025; period end 2025-12-31; filed 2026-02-19; reporting currency USD
source · NUM_MET_REVENUE_FY2025
60,774,000,000
FY 2025; period end 2025-12-31; filed 2026-02-12; reporting currency USD
source · NUM_PRU_REVENUE_FY2025
23,698,000,000
FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD
source · NUM_RGA_REVENUE_FY2025
18,481,000,000
FY 2025; period end 2025-12-31; filed 2026-02-11; reporting currency USD
source · NUM_CRBG_REVENUE_FY2025
18,212,000,000
FY 2025; period end 2025-12-31; filed 2026-02-19; reporting currency USD
source · NUM_LNC_REVENUE_FY2025
8,189,000,000
FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD
source · NUM_VOYA_REVENUE_FY2025
7,301,000,000
FY 2025; period end 2025-12-31; filed 2026-02-27; reporting currency USD
source · NUM_GNW_REVENUE_FY2025
6,766,000,000
FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD
source · NUM_BHF_REVENUE_FY2025
6,683,000,000
FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD
source · NUM_JXN_REVENUE_FY2025
5,994,318,000
FY 2025; period end 2025-12-31; filed 2026-02-25; reporting currency USD
source · NUM_GL_REVENUE_FY2025
Net margin4.38%
FY 2025; period end 2025-12-31; filed 2026-02-19
source · NUM_MET_NET_MARGIN_FY2025
5.88%
FY 2025; period end 2025-12-31; filed 2026-02-12
source · NUM_PRU_NET_MARGIN_FY2025
4.99%
FY 2025; period end 2025-12-31; filed 2026-02-20
source · NUM_RGA_NET_MARGIN_FY2025
-1.98%
FY 2025; period end 2025-12-31; filed 2026-02-11
source · NUM_CRBG_NET_MARGIN_FY2025
6.46%
FY 2025; period end 2025-12-31; filed 2026-02-19
source · NUM_LNC_NET_MARGIN_FY2025
7.99%
FY 2025; period end 2025-12-31; filed 2026-02-20
source · NUM_VOYA_NET_MARGIN_FY2025
3.05%
FY 2025; period end 2025-12-31; filed 2026-02-27
source · NUM_GNW_NET_MARGIN_FY2025
6.40%
FY 2025; period end 2025-12-31; filed 2026-02-24
source · NUM_BHF_NET_MARGIN_FY2025
0.40%
FY 2025; period end 2025-12-31; filed 2026-02-24
source · NUM_JXN_NET_MARGIN_FY2025
19.37%
FY 2025; period end 2025-12-31; filed 2026-02-25
source · NUM_GL_NET_MARGIN_FY2025
Operating marginQuarantined: Only 2 of 10 companies have a verified fact; threshold is 4.
Free cash flowQuarantined: Only 1 of 10 companies have a verified fact; threshold is 4.
Capital expendituresQuarantined: Only 1 of 10 companies have a verified fact; threshold is 4.
Dividends paid1,509,000,000
FY 2025; period end 2025-12-31; filed 2026-02-19; reporting currency USD
source · NUM_MET_DIVIDENDS_PAID_FY2025
1,926,000,000
FY 2025; period end 2025-12-31; filed 2026-02-12; reporting currency USD
source · NUM_PRU_DIVIDENDS_PAID_FY2025
240,000,000
FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD
source · NUM_RGA_DIVIDENDS_PAID_FY2025
511,000,000
FY 2025; period end 2025-12-31; filed 2026-02-11; reporting currency USD
source · NUM_CRBG_DIVIDENDS_PAID_FY2025
325,000,000
FY 2025; period end 2025-12-31; filed 2026-02-19; reporting currency USD
source · NUM_LNC_DIVIDENDS_PAID_FY2025
178,000,000
FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD
source · NUM_VOYA_DIVIDENDS_PAID_FY2025
Not available.Not available.223,000,000
FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD
source · NUM_JXN_DIVIDENDS_PAID_FY2025
86,067,000
FY 2025; period end 2025-12-31; filed 2026-02-25; reporting currency USD
source · NUM_GL_DIVIDENDS_PAID_FY2025
Share buybacks2,883,000,000
FY 2025; period end 2025-12-31; filed 2026-02-19; reporting currency USD
source · NUM_MET_SHARE_BUYBACKS_FY2025
1,000,000,000
FY 2025; period end 2025-12-31; filed 2026-02-12; reporting currency USD
source · NUM_PRU_SHARE_BUYBACKS_FY2025
Not available.2,118,000,000
FY 2025; period end 2025-12-31; filed 2026-02-11; reporting currency USD
source · NUM_CRBG_SHARE_BUYBACKS_FY2025
0.00
FY 2024; period end 2024-12-31; filed 2025-02-21; reporting currency USD
source · NUM_LNC_SHARE_BUYBACKS_FY2024
Non-aligned period: 2024-Q4; row majority 2025-Q4.
200,000,000
FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD
source · NUM_VOYA_SHARE_BUYBACKS_FY2025
247,000,000
FY 2025; period end 2025-12-31; filed 2026-02-27; reporting currency USD
source · NUM_GNW_SHARE_BUYBACKS_FY2025
102,000,000
FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD
source · NUM_BHF_SHARE_BUYBACKS_FY2025
669,000,000
FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD
source · NUM_JXN_SHARE_BUYBACKS_FY2025
880,983,000
FY 2025; period end 2025-12-31; filed 2026-02-25; reporting currency USD
source · NUM_GL_SHARE_BUYBACKS_FY2025
Assets745,166,000,000
FY 2025; period end 2025-12-31; filed 2026-02-19; reporting currency USD
source · NUM_MET_ASSETS_FY2025
773,740,000,000
FY 2025; period end 2025-12-31; filed 2026-02-12; reporting currency USD
source · NUM_PRU_ASSETS_FY2025
156,590,000,000
FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD
source · NUM_RGA_ASSETS_FY2025
413,547,000,000
FY 2025; period end 2025-12-31; filed 2026-02-11; reporting currency USD
source · NUM_CRBG_ASSETS_FY2025
417,204,000,000
FY 2025; period end 2025-12-31; filed 2026-02-19; reporting currency USD
source · NUM_LNC_ASSETS_FY2025
178,859,000,000
FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD
source · NUM_VOYA_ASSETS_FY2025
88,083,000,000
FY 2025; period end 2025-12-31; filed 2026-02-27; reporting currency USD
source · NUM_GNW_ASSETS_FY2025
241,800,000,000
FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD
source · NUM_BHF_ASSETS_FY2025
352,586,000,000
FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD
source · NUM_JXN_ASSETS_FY2025
30,813,692,000
FY 2025; period end 2025-12-31; filed 2026-02-25; reporting currency USD
source · NUM_GL_ASSETS_FY2025
Liabilities / equity25.22
FY 2025; period end 2025-12-31; filed 2026-02-19
source · NUM_MET_LIABILITIES_TO_EQUITY_FY2025
22.76
FY 2025; period end 2025-12-31; filed 2026-02-12
source · NUM_PRU_LIABILITIES_TO_EQUITY_FY2025
10.63
FY 2025; period end 2025-12-31; filed 2026-02-20
source · NUM_RGA_LIABILITIES_TO_EQUITY_FY2025
30.27
FY 2025; period end 2025-12-31; filed 2026-02-11
source · NUM_CRBG_LIABILITIES_TO_EQUITY_FY2025
37.25
FY 2025; period end 2025-12-31; filed 2026-02-19
source · NUM_LNC_LIABILITIES_TO_EQUITY_FY2025
34.69
FY 2025; period end 2025-12-31; filed 2026-02-20
source · NUM_VOYA_LIABILITIES_TO_EQUITY_FY2025
8.95
FY 2025; period end 2025-12-31; filed 2026-02-27
source · NUM_GNW_LIABILITIES_TO_EQUITY_FY2025
34.72
FY 2025; period end 2025-12-31; filed 2026-02-24
source · NUM_BHF_LIABILITIES_TO_EQUITY_FY2025
34.39
FY 2025; period end 2025-12-31; filed 2026-02-24
source · NUM_JXN_LIABILITIES_TO_EQUITY_FY2025
4.16
FY 2025; period end 2025-12-31; filed 2026-02-25
source · NUM_GL_LIABILITIES_TO_EQUITY_FY2025

Code-computed comparisons

Market-risk companion: risk and factor comparison from lmfin. It is descriptive and separate from the SEC fundamentals review.

Narrative Matrix

DimensionMETPRURGACRBGLNCVOYAGNWBHFJXNGL
Business modelQuarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.
Geographic and customer exposureQuarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.
Capital allocationQuarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.
Stated strategy in filingsQuarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.
Idiosyncratic risks in filingsQuarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.
Recent narrative changeQuarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.

Gate summary

Facts: 61. Claims survived: 0. Claims dropped: 0. Cells quarantined: 60.

Quarantined quantitative rows

Quarantined dimensions

Quarantined cells